Analyzing the divergent paths undertaken by small biotech and large pharma companies in drug development.
Ray Forslund, PhD, MBA
Advertisement
Articles by Ray Forslund, PhD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
2
The Key to Connecting with Patients: Pharma's Market Access Transformation
3
Alcami Brings Third Sterile Fill-Finish Line Online. Expanding Clinical-to-Commercial Capacity
4
Trade & Channel Strategies 2025: Inside Pharma’s Turning Point
5